Targeting CRABP-II Overcomes Pancreatic Cancer Drug Resistance By Reversing Lipid Raft Cholesterol Accumulation and AKT Survival Signaling
Shuiliang Yu(Case Western Reserve University), Lan Zhou(Brigham and Women's Hospital)
Cited by 3
Related Papers
FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration
|Oncology Reports|2016|26